ClinicalTrials.Veeva

Menu
East Florida Eye Institute | Stuart logo

East Florida Eye Institute | Stuart

Research site
About
East Florida Eye Institute is at the forefront of ophthalmic research, contributing to the development of innovative treatments for eye conditions. We are excited to offer our patients the opportunity to participate in groundbreaking studies.

Site insights

Top conditions

Top treatments

APL-2
Abicipar Pegol
RVL-1201
Bimatoprost
Aflibercept
Bevacizumab
Squalamine Lactate
Ranibizumab
PVP
Timolol Maleate

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Joe Boban

Verified by this site

Active trials

5 of 26 total trials

A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

The purpose of this study is to evaluate change in geographic atrophy (GA) lesion growth of eyes treated with JNJ-81201887 compared to sham control.

Active, not recruiting
Geographic Atrophy
Drug: Triamcinolone
Other: Sham Procedure

Researchers are looking for a better way to treat people who have macular edema secondary to retinal vein occlusion (RVO).In people with RVO, a blood...

Active, not recruiting
Macular Edema Secondary to Retinal Vein Occlusion
Drug: Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_2 mg
Drug: Sham

This is a multicenter, open-label, dose escalation (Cohort 1) to masked, randomized, parallel-groups (Cohort 2) and (Cohort 3) study to evaluate the...

Enrolling
Open-angle Glaucoma
Ocular Hypertension
Other: Sham Administration
Drug: AGN-193408 SR

This is a phase 3, open-label, multicenter, extension study to evaluate the long-term safety and efficacy of pegcetacoplan (APL-2) in subjects with g...

Active, not recruiting
Geographic Atrophy Secondary to Age-related Macular Degeneration
Drug: PEGCETACOPLAN (APL-2)

The purpose of this study is to assess long-term safety of avacincaptad pegol intravitreal administration for patients with geographic atrophy (GA) w...

Active, not recruiting
Age-Related Macular Degeneration
Geographic Atrophy
Drug: avacincaptad pegol

Trial sponsors

Allergan logo
A
R
S
Shire logo
AbbVie logo
Aerie Pharmaceuticals logo
Astellas logo
Bayer logo
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems